The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- PureTech: Licensing and Equity Agreement with Novartis (2017-03-24)
> Program to initially focus on aging-related disorders > Phase 2b clinical study to commence in 2017 PureTech Health plc (LSE: PRTC), an advanced clinical stage biopharmaceutical company, today announced a licensing and equity agreement with Novartis to ad...
- Merck/Pfizer: FDA Approves Bavencio (avelumab) for mMCC (2017-03-23)
> Only FDA-approved treatment for metastatic Merkel cell carcinoma, a rare and aggressive skin cancer > First indication for BAVENCIO, a human anti-PD-L1 antibody Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FD...
- Medigene Discloses Target for First Clincial TCRTrial (2017-03-23)
Medigene AG (FSE: MDG1, Prime Standard, TecDAX), today announced details on the Company's first clinical trial with T-cell receptor-modified T cells, planned to start in late 2017. Medigene will use an HLA-A2:01-restricted T-cell receptor (TCR) that targets PRAME, ...
- Medigene Publishes 2016 Annual Report and Outlook for 2017 (2017-03-23)
- Total revenue increases 43% to Eur9.8 m - Cash and cash equivalents rise to Eur52.6 m - Financial guidance for 2016 met - Strategic partnership with bluebird bio for T cell receptors - Phase II of the Phase I/II clinical trial of DC vaccines g...
- MorphoSys’s CSO Marlies Sproll Takes Temporary Leave (2017-03-23)
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY), a leader in the field of therapeutic antibodies, today announced that Dr. Marlies Sproll, the Company's long-standing Chief Scientific Officer, will be on temporary leave from her CSO position for...
- BASF Licenses CRISPR-Cas9 Technology from Broad Institute (2017-03-22)
> Global licensing agreement to provide improved products in agricultural and industrial applications > Genome editing seen as the next revolution in biotechnology BASF today announced that it has reached a global licensing agreement with the Broad Institut...
- GSK investiert €162m in neue Impfstoffproduktion in Marburg (2017-03-20)
> Symbolischer Spatenstich für den Neubau einer Antigen-Produktion für Meningokokken-B-Impfstoff in Marburg > GSK investiert 162 Mio € in die Produktion des zukunftsweisenden Impfstoffs als klares Signal für den Standort > GSK unterstreicht erneut sein langfr...
- AC Immune Reports 2016 Financial Results (2017-03-17)
> Strong cash position of CHF 152.2 million provides resources to advance pipeline of seven therapeutic and three diagnostic candidates > Successful IPO on NASDAQ raised net proceeds of CHF 69.4 million > Important data on crenezumab supporting 60mg/kg dose...
- Lonza Launches New Hepatocytes for ADME-Tox Testing (2017-03-16)
Lonza now offers a comprehensive portfolio of fresh and cryopreserved human and animal hepatocytes for ADME-Tox testing, further strengthening its position as a leader in cell discovery. This expansion of Lonza’s primary cells range is the result of last year’s acq...
- Cevec, Medac and Provecs: Adenoviral Vector Collaboration (2017-03-16)
> Project will cover the entire process from R&D up to manufacturing and clinical development of adenoviral vectors for medac’s oncology products using CEVEC’s proprietary CAP®GT technology > Collaboration is next step in setting CAP®GT as global standard in ade...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to email@example.com and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)